These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24140174)

  • 61. Involvement of a state society of hospital pharmacists in third-party reimbursement for nondistributive services.
    Breland BD; Hayman JN
    Am J Hosp Pharm; 1982 Nov; 39(11):1937-9. PubMed ID: 7148865
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost-effectiveness considerations with molecular diagnostics in oncology.
    Brunstein J
    MLO Med Lab Obs; 2016 May; 48(5):30-1. PubMed ID: 27326449
    [No Abstract]   [Full Text] [Related]  

  • 63. Are you responsible for medical director duties in anatomic pathology--and why should you care?
    Hernandez JS
    Adv Anat Pathol; 2011 Jan; 18(1):75-8. PubMed ID: 21169740
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Critical diagnoses (critical values) in anatomic pathology.
    ; Silverman JF; Fletcher CD; Frable WJ; Goldblum JR; Pereira TC; Swanson PE
    Hum Pathol; 2006 Aug; 37(8):982-4. PubMed ID: 16867859
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Integration of professionalism and volunteerism in building the foundation of the "International Institute of Breast Pathology" a worldwide collaboration.
    Masood S
    Breast J; 2008; 14(2):125-7. PubMed ID: 18315689
    [No Abstract]   [Full Text] [Related]  

  • 66. Q-Probes studies in anatomic pathology: quality improvement through targeted benchmarking.
    Tworek JA; Volmar KE; McCall SJ; Bashleben CP; Howanitz PJ
    Arch Pathol Lab Med; 2014 Sep; 138(9):1156-66. PubMed ID: 25171698
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Projecting corporate health plan utilization and charges from annual ICD-9-CM diagnostic rates: a value-added opportunity for pathologists.
    Elevitch FR; Silvers A; Sahl JD
    Arch Pathol Lab Med; 1997 Nov; 121(11):1187-91. PubMed ID: 9372747
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Robust, reliable and resilient: designing molecular tuberculosis tests for microscopy centers in developing countries.
    Denkinger CM; Kik SV; Pai M
    Expert Rev Mol Diagn; 2013 Nov; 13(8):763-7. PubMed ID: 24151844
    [No Abstract]   [Full Text] [Related]  

  • 69. Review of occupational medicine practice guidelines for interventional pain management and potential implications.
    Manchikanti L; Singh V; Derby R; Helm S; Trescot AM; Staats PS; Prager JP; Hirsch JA
    Pain Physician; 2008; 11(3):271-89. PubMed ID: 18523500
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Critical pathways and cost-effective practice.
    Patterson RB; Whitley D; Porter K
    Semin Vasc Surg; 1997 Jun; 10(2):113-8. PubMed ID: 9203263
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
    Willems P
    Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Standards and specifications in pathology: image management, report management and terminology.
    Daniel C; Booker D; Beckwith B; Della Mea V; GarcĂ­a-Rojo M; Havener L; Kennedy M; Klossa J; Laurinavicius A; Macary F; Punys V; Scharber W; Schrader T
    Stud Health Technol Inform; 2012; 179():105-22. PubMed ID: 22925792
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pathologists' roles in clinical utilization management. A financing model for managed care.
    Zhao JJ; Liberman A
    Am J Clin Pathol; 2000 Mar; 113(3):336-42. PubMed ID: 10705812
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tracing our roots: new opportunities and new challenges in clinical laboratory science (1977-1992).
    Kotlarz VR
    Clin Lab Sci; 2001; 14(1):13-8. PubMed ID: 15633489
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Laboratory developed tests in the clinical laboratory: challenges for implementation.
    Marzinke MA; Clarke W
    Bioanalysis; 2015; 7(15):1817-20. PubMed ID: 26295983
    [No Abstract]   [Full Text] [Related]  

  • 76. Add to cart?
    Hale I
    Can Fam Physician; 2015 Nov; 61(11):937-9, 941-4. PubMed ID: 26564649
    [No Abstract]   [Full Text] [Related]  

  • 77. [RIHN: A new plan to support innovation in laboratory medicine and pathology by the French Ministry of Health. The analysis of the French Society of Pathology (SFP)].
    Scoazec JY
    Ann Pathol; 2016 Jun; 36(3):161-5. PubMed ID: 27237606
    [No Abstract]   [Full Text] [Related]  

  • 78. [Lean management in the pathology laboratory].
    Blank A; Dawson H; Hammer C; Perren A; Lugli A
    Pathologe; 2017 Nov; 38(6):540-544. PubMed ID: 29043447
    [No Abstract]   [Full Text] [Related]  

  • 79. Philippe Vielh, Cytopathology's new Editor-in-Chief.
    Cytopathology; 2021 Jan; 32(1):6. PubMed ID: 33368670
    [No Abstract]   [Full Text] [Related]  

  • 80. A Plea For the Development of Pathology: Oscar T. Schultz, M.D., Chicago.
    JAMA; 2022 Dec; 328(24):2461. PubMed ID: 36573987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.